We provide a review of current literature and report on a case of electronic device infective endocarditis with C. tropicalis. A 64-year-old man presented for revision of his implantable cardioverter defibrillator. Echocardiography revealed extensive vegetations attached to the Eustachian valve and in the right ventricular apex. Microbiological findings presented C. tropicalis on the explanted material. The patient refused additional surgical intervention. We successfully treated the patient with liposomal Amphotericin B and Flucytosine for 8 weeks.
Introduction
Endocarditis is a severe infectious disease with a high proportion of fatal courses [1] [2] [3] [4] [5] [6] [7] . In-hospital mortality ranges from 12% to 17% for native valve endocarditis, 23%-26% for prosthetic valve endocarditis, 10% for cardiac implantable electronic device infective endocarditis (CIED-IE), and 8% for right-sided endocarditis. There are numerous factors known to increase mortality, such as heart failure, renal failure, diabetes, male sex, and higher age. Moreover, hospital-acquired endocarditis, endocarditis location, cardiac resynchronization therapy as well as persistent infection, and cardiac, hemodynamic and neurological complications are relevant risk factors [3, [5] [6] [7] [8] [9] [10] [11] .
Around 70% of endocarditis cases are native valve endocarditis and 21%-25% are prosthetic valve endocarditis. Other than that, CIED-IE accounts for about 5% of all endocarditis cases. Likewise, right-sided endocarditis, mainly caused by CIED-IE, accounts for 8.5% [3, 4, 8] . In recent decades, the number of CIED-IE has increased in a more progressive manner than the number of device implantations [12, 13] . This highlights the healthcare burden of CIED-IE [14] . Certain risk factors such as renal insufficiency, male sex, anticoagulant use, long-term corticosteroid treatment, number of pacing leads, device revision and prior device procedures are associated with the incidence of CIED-IE. Perioperative antibiotic use has a protective effect [15] [16] [17] [18] [19] . Regarding aetiology, S. aureus, coagulase-negative staphylococci, and viridans group streptococci are the most common pathogens for endocarditis. However, about 2% account for fungal endocarditis [3] [4] [5] [6] 10, 20] . The majority of fungaemia cases are contributed to C. albicans (52.1%) and C. glabrata (28.0%) whereas C. tropicalis only accounts for about 4.1% [21] . Thus, Candida species are the most common cause of fungal endocarditis. In particular, C. tropicalis causes up to 9% of Candida endocarditis and up to 13% of Candida CIED-IE [22, 23] . Nevertheless, Aspergillus species may also account for 11-24% of fungal endocarditis cases [20, 24] . The sensitivity of blood cultures to detect Candida is 50-70% [25] which may result in blood culture negative infective endocarditis and thus in a postponed start for optimal therapy.
Candida endocarditis is difficult to treat and often associated with a poor outcome. Baddley et al. showed a significant difference in mortality among Candida patients and patients with non-fungal endocarditis of 30.3% vs. 17.0%, respectively [22] . Others described mortality rates of 33.3% in fungal endocarditis compared to 14.8% in non-fungal endocarditis and 46.6% in Candida endocarditis compared to 16.1% in non-Candida endocarditis [3, 26] .
In this case report we present a rare case of C. tropicalis implantable cardioverter defibrillator endocarditis combined with an endocarditis affecting the right ventricular lead, the right ventricle and the Eustachian valve.
Case
The patient, a 64-year-old man with one vessel coronary artery disease, chronic kidney disease and paroxysmal atrial fibrillation presented for a right ventricular lead revision of his single chamber 14 months earlier, the patient underwent cardiopulmonary resuscitation due to ventricular tachycardia. He was treated on the intensive care unit in an external hospital for 42 days. He was mechanical ventilated for the first 28 days and catecholamine therapy was required for the first 13 days. Continuous venovenous hemodiafiltration was performed from day 3 to day 14 due to sepsis with multiple organ failure. The patient developed a prolonged pneumonia, which was caused by chlamydia (Serological testing day 24) and treated with Piperacillin/Tazobactam, Ciprofloxacin and Clarithromycin. Due to colonic diverticular bleeding eight erythrocyte concentrates were transfused. The patient developed a C. tropicalis sepsis. C. tropicalis was detected in faecal and blood cultures 17 days after the survived sudden cardiac death and was treated with Caspofungin for 2 weeks. Following the antifungal therapy, blood cultures were negative. An implantable cardioverter defibrillator was implanted for secondary prevention. One appropriate shock was applied due to ventricular fibrillation 5 weeks after implantation. 7 months later, the right ventricular lead showed a loss of sensing and was replaced. At that time, a transthoracic echocardiography showed no abnormalities.
On admission, 14 months after the survived sudden cardiac death and 7 months after the first replacement of the ICD, there was a moderate rise in the C-reactive protein level (2.0 mg/dl) and a slightly reduced glomerular filtration rate (71 ml/min). Otherwise, laboratory findings and clinical examination as well as chest X-Ray were inconspicuous. Surprisingly, a pus-filled ICD pocket was observed during surgery. The extracted lead was covered with thin vegetations. Implantation of a new internal cardio defibrillator was postponed. A large floating mass on the Eustachian valve measuring 40 × 17 mm (Fig. 1 ) and a smaller floating mass located in the right ventricular apex measuring 22 × 15 mm (Fig. 2) was detected by echocardiography (day 0).
To detect C. tropicalis on the ICD and its lead the matrix-assisted laser desorption ionization-time of flight mass spectrometry (Bruker After +7 days of treatment, the floating masses were markedly reduced in size. Transthoracic echocardiography showed to be superior in visualizing the floating masses compared to transoesophageal echocardiography. At day +9 of antifungal treatment, a thoracic computer tomography showed no signs of thromboembolic events or miliary pulmonary infiltration. At day +15, an asymptomatic elevation of the systolic right ventricular pressure (50 mmHg), which was possibly caused by pulmonary embolism, was observed in a transthoracic ultrasound. During the stay, the C-reactive protein levels were slightly elevated (1.0 mg/dl -6.1 mg/dl) whereas leucocytes, blood sedimentation rate, and the procalcitonine level were normal. Blood cultures were taken on a regular basis but revealed no fungaemia. The patient developed two febrile episodes due to lower urinary tract infections caused by E. faecalis and E. faecium (day +9 and + 22). Consequently, the patient was treated with Piperacillin/Tazobactam 3.0 g/1.5 g t.i.d. (day +9 to +16 and day+22 to +24) and Levofloxacin 250 mg q.d. (day +24 to +29) following the resistogram. Further urological assessments showed no abnormalities. Furthermore, funduscopic examination showed no signs of chorioretinitis. While on treatment with liposomal Amphotericin B and Flucytosine, creatinine levels rose continuously from 1.1 mg/dl to 1.7 mg/dl. At day +27, we reduced the dose of liposomal Amphotericin B from 5 mg/kg to 3 mg/ kg. Following dose reduction, creatinine levels remained constant. The floating masses in the right ventricle and on the Eustachian valve reduced continuously on day +15, +22, +29, +36, +43 and + 54. On day +54 the Eustachian valve mass was cleared. The mass in the apex of the right ventricle measured 3 × 2 mm. After +8 weeks of antifungal therapy with liposomal Amphotericin B and Flucytosine, we discharged the patient with a wearable cardioverter defibrillator and without further antifungal prophylaxis.
4 weeks following hospital dismissal, we saw the patient again for subcutaneous ICD implantation to avoid further lead complications. Transthoracic and transoesophageal echocardiography showed no intracardiac vegetations. The floating structures on the Eustachian valve and in the right ventricle could not been visualized. Blood tests showed no signs of infection and creatinine was 1.3 mg/dl. Blood cultures taken showed no signs of fungaemia or bacteraemia.
Follow-ups at 2, 6 and 14 months after the antifungal treatment showed no evidence of vegetations in transthoracic echocardiography.
Discussion
As demonstrated earlier, Candida IE in particular and fungal IE in general present very severe infectious diseases with poor outcome and multiple complications. Lefort et al. indicated a rate for embolic complications in 73% of Candida IE [27] whereas Baddley et al. did not observe an increased risk for embolization in fungal IE [22] . In CIED-IE lead, vegetation size and mobility do not correlate with the occurrence of pulmonary embolism. Only systemic embolism increases the overall mortality [28] . Nevertheless, large vegetations, as described in our case, may increase the risk for fulminant pulmonary embolism [28] . Yet, there is a significant number of silent pulmonary as well as systemic embolisms [19, [29] [30] [31] . The risk for an embolism reduces continuously over time after initiation of medical treatment with having the lowest risk 2 weeks following the initiation of causative medical treatment [2, 29, 32, 33] . For CIED-IE, device removal is regarded as primary therapy [8, 34, 35] . There is evidence that percutaneous lead extraction is safe even in the case of lead vegetations larger than 2 cm [36] [37] [38] [39] [40] . With regard to the fungal aetiology, the large vegetations of the Eustachian valve and the apex of the right ventricle, early surgery which was refused by the patient would have been indicated [34] . Here, alternatively to an open surgery, minimal invasive extraction of large CIED-IE and large right-sided IE vegetations with an AngioVac system [41] [42] [43] [44] [45] [46] [47] [48] [49] or with a wire snare [50] might prove beneficial.
Regarding medical therapy, the combination therapy of liposomal Amphotericin B and Flucytosine ought to be performed for 6-8 weeks alone or in combination with surgery [34] . Caspofungin might be used instead of liposomal Amphotericin B [34] . Since our patient already received Caspofungin treatment for C. tropicalis sepsis 14 months earlier, we preferred liposomal Amphotericin B. Candida biofilms are more susceptible to liposomal Amphotericin B than deoxycholate Amphotericin B [51] . Nephrotoxicity and transfusion related reactions for liposomal Amphotericin B are also less pronounced [52] .
After the survived sudden cardiac death 14 months earlier, our patient was qualified for a reimplantation of an internal cardiac defibrillator. Due to the limited data of fungal CIED-IE and fungal IE, we decided to postpone the reimplantation until 4 weeks after the end of the antifungal therapy. During this time, we equipped the patient with a wearable cardioverter defibrillator. Several authors showed that bridging with a wearable cardioverter defibrillator is effective in preventing sudden cardiac death [53] [54] [55] [56] . To avoid further lead complications we implanted a totally subcutaneous ICD. According to current data, evidence for fungistatic Fluconazole prophylaxis was not strong enough for life long treatment [57] . Following antifungal therapy regimen with Amphotericin B and Flucytosine, the patient did not show signs of a relapse after 14 months.
With regard to the microbiological circumstances in the present case, we performed a PubMed based search for Candida CIED-IE and Candida Eustachian valve endocarditis. Case reports with uncompleted data and non-English case reports were excluded. The Eustachian valve, first described by the Italian anatomist Bartolomeo Eustachi [58] , is rarely affected by an endocarditis [59] . It is located in the inferior right atrium and a remnant of the foetal heart, which has no particular function in adults. Our search revealed only two cases of Candida Eustachian valve endocarditis, which are presented in Table 1 [60, 61] . In total, there are 26 cases of Candida CIED-IE and 5 cases of C. tropicalis CIED-IE, which are summarized in Table 2 .
The present case adds important information to the current literature as it clearly demonstrates successful conservative therapy in a patient with extensive fungal vegetations.
Conflict of interest
There are none.
